Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07877649

Longitudinal Registry of Difficult-to-Treat Inflammatory Bowel Disease

Sponsor: First Affiliated Hospital, Sun Yat-Sen University

View on ClinicalTrials.gov

Summary

Difficult-to-treat inflammatory bowel disease (DTT-IBD) represents a heterogeneous group of patients with treatment-refractory, structurally complicated, postoperative, perianal, pouch-related, or psychosocially complex disease. This multicentre ambidirectional observational cohort will establish a longitudinal registry of adults with inflammatory bowel disease and systematically identify patients meeting prespecified DTT-IBD criteria. Clinical data will be reconstructed retrospectively and collected prospectively using a common data dictionary, including disease phenotype, advanced-therapy exposure and failure, objective disease assessments, multidisciplinary decision-making, treatment implementation, surgery, hospitalization, and long-term outcomes. The registry will characterize the occurrence, clinical domains, treatment trajectories, longitudinal disease-control states, and outcomes of DTT-IBD. No treatment, diagnostic test, dose, surgery, or monitoring procedure will be assigned by the study. Clinical management will remain entirely at the discretion of the treating physicians and patients. The platform is designed to support prespecified nested studies addressing treatment-failure mechanisms and clinical decisions, longitudinal DTT trajectories and cumulative uncontrolled disease, and implementation of multidisciplinary care.

Official title: A Multicentre Observational Cohort Study of Difficult-to-Treat Inflammatory Bowel Disease

Key Details

Gender

All

Age Range

16 Years - Any

Study Type

OBSERVATIONAL

Enrollment

2000

Start Date

2026-11-01

Completion Date

2032-12-31

Last Updated

2026-10-16

Healthy Volunteers

No

Interventions

OTHER

Routine IBD Management and Advanced-Therapy Exposure

Treatment exposure, optimization, switching, discontinuation, surgery, monitoring, and multidisciplinary management occurring as part of routine clinical care. No exposure is assigned by the study protocol.